Trials / Completed
CompletedNCT00617903
Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea
A 12-week Exploratory, Multicenter, Double-blind, Vehicle-controlled Study to Investigate the Efficacy and Safety of Topical Azelaic Acid 15% Foam Twice Daily in Patients With Papulopustular Rosacea
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 83 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This exploratory study is being performed to determine whether a new form formulation of azelaic acid 15% is effective in the treatment of papulopustular rosecea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azelaic acid | 15% foam to be applied topically twice daily |
| DRUG | Vehicle foam | Active-ingredient-free vehicle to be applied topically twice daily |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-02-18
- Last updated
- 2020-04-07
- Results posted
- 2013-07-04
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00617903. Inclusion in this directory is not an endorsement.